Liothyronine Sodium Tablet
Product Images NDC 43063-884

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 43063-884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063884)

Image (43063884)
Label for Liothyronine Sodium USP 25 mcg tablets, prescription drug by PD-Rx Pharmaceuticals, Inc. The label states package includes 30 tablets. The NDC numbers 43063-884-30 and 43063-884-30-30 are visible. The label includes dosage warnings, reorder number, lot number 119E83, and expiration date 09/2021. The label features the PD-Rx Pharmaceuticals logo and barcode.*
FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure diagram of Liothyronine Sodium showing the molecular arrangement and formula C15H11I3NNaO4 with a molecular weight of 672.96.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.